Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Su Miin Ong"'
Autor:
Audrey Huili Lim, Norazida Ab Rahman, Su Miin Ong, Siti Raidah Mohamad Azman, Fairus Zana Mohd Rathi, Mastura Ismail, Peter Seah Keng Tok, Bee Kiau Ho, Sheamini Sivasampu
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background: The National Antimicrobial Guidelines (NAG) 2014 and NAG2019 in Malaysia targeted rational and judicious use of antimicrobials. In this study, we assessed the change in antibiotic utilisation and appropriateness due to the guidelines that
Externí odkaz:
https://doaj.org/article/b0462dc2901e47f3b9108d28a03a7552
Publikováno v:
BMC Primary Care, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background While patients’ preferences in primary care have been examined in numerous conjoint analyses, there has been little systematic effort to synthesise the findings. This review aimed to identify, to organise and to assess the stren
Externí odkaz:
https://doaj.org/article/e425870fd80b46f586644a4753992119
Autor:
Norazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, Su Miin Ong, Kalaiarasu M. Peariasamy, Sheamini Sivasampu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
In response to Coronavirus disease 2019 (COVID-19) global pandemic, various COVID-19 vaccines were rapidly administered under emergency use authorization. Rare outcomes associated with COVID-19 vaccines might be less likely to be captured in clinical
Externí odkaz:
https://doaj.org/article/ed43f8fd106c47dd9623d5fa5ab3a20e
Autor:
Yvonne Mei Fong Lim, Su Miin Ong, Stefan Koudstaal, Wen Yea Hwong, Houng Bang Liew, Jeyamalar Rajadurai, Diederick E. Grobbee, Folkert W. Asselbergs, Sheamini Sivasampu, Ilonca Vaartjes
Publikováno v:
Global Heart, Vol 17, Iss 1 (2022)
Background and objectives: Data on population-level outcomes after heart failure (HF) hospitalisation in Asia is sparse. This study aimed to estimate readmission and mortality after hospitalisation among HF patients and examine temporal variation by
Externí odkaz:
https://doaj.org/article/9aa360cf05c5463e83dbdc3188fb4a52
Autor:
Su Miin Ong, Ming Tsuey Lim, Seng Fah Tong, M N Kamaliah, Peter Groenewegen, Sheamini Sivasampu
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276480 (2022)
IntroductionPrimary care services are essential in achieving universal health coverage and Malaysia is looking into public-private partnership to overcome resource constraints. The study aims to compare the performance of primary care service deliver
Externí odkaz:
https://doaj.org/article/89e6635402fa4618b0e68b11bcbfba78
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Objectives Most countries including Malaysia have set goals to incorporate a strong primary care into the healthcare system. The aim of this study was to evaluate the strength of service delivery process dimensions in Malaysia and compare it with Eng
Externí odkaz:
https://doaj.org/article/2127583f7e36456291e8cf7f67f50ff6
Publikováno v:
BMC Geriatrics, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Polypharmacy is particularly important in older persons as they are more likely to experience adverse events compared to the rest of the population. Despite the relevance, there is a lack of studies on the possible association of
Externí odkaz:
https://doaj.org/article/cbd97da137c44953a10bafe639db661b
Autor:
Jing Lian Suah, Peter Seah Keng Tok, Su Miin Ong, Masliyana Husin, Boon Hwa Tng, Sheamini Sivasampu, Thevesh Thevananthan, Maheshwara Rao Appannan, Faizah Muhamad Zin, Shahanizan Mohd Zin, Hazlina Yahaya, Norhayati Rusli, Mohd Fikri Ujang, Hishamshah Mohd Ibrahim, Noor Hisham Abdullah, Kalaiarasu M. Peariasamy
Publikováno v:
Vaccines, Vol 9, Iss 12, p 1381 (2021)
Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222, BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine effectiveness with two methods, covering 1 April to 15 September 2021: (1) the screen
Externí odkaz:
https://doaj.org/article/cdbf934d627c445cb11606e647a8cff3
Autor:
Sheamini Sivasampu, Maheshwara Rao Appannan, Peter Seah Keng Tok, Norhayati Rusli, Boon Hwa Tng, Faizah Muhamad Zin, Shahanizan Mohd Zin, Jing Lian Suah, Su Miin Ong, Masliyana Husin, Hazlina Yahaya, Mohd Fikri Ujang, Hishamshah Mohd Ibrahim, Thevesh Thevananthan, Noor Hisham Abdullah, Kalaiarasu M. Peariasamy
Publikováno v:
Vaccines, Vol 9, Iss 1381, p 1381 (2021)
Vaccines; Volume 9; Issue 12; Pages: 1381
Vaccines
Vaccines; Volume 9; Issue 12; Pages: 1381
Vaccines
Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222, BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine effectiveness with two methods, covering 1 April to 15 September 2021: (1) the screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fed6ca035c892abe8b88ea225900c7b
https://www.mdpi.com/2076-393X/9/12/1381
https://www.mdpi.com/2076-393X/9/12/1381
Autor:
Su Miin Ong, Yvonne Mei Fong Lim, Wen Yea Hwong, Stefan Koudstaal, Houng Bang Liew, Annamalar Muthu Muthuppalaniappan, Folkert W Asselbergs, Diederick E Grobbee, Ilonca Vaartjes, Sheamini Sivasampu
Introduction Almost no country-specific incidence trends data of de novo heart failure (HF) hospitalisations are available for Southeast Asia. This study aimed to determine the trends in incidence of HF hospitalisations and how these differ by age, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9a849061c7da148a297801251ca384
